Works by Katlama, Christine

Results: 179
    1

    IMPACT OF VACCINATION ON MPOX INCIDENCE IN MSM ON PrEP IN THE ANRS 174 DOXYVAC TRIAL.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 86
    By:
    • Ghosn, Jade;
    • Assoumou, Lambert;
    • Ouattara, Moussa;
    • Algarte-Genin, Michele;
    • Rubenstein, Emma;
    • Pialoux, Gilles;
    • Katlama, Christine;
    • Surgers, Laure;
    • Duvivier, Claudine;
    • Pavie, Juliette;
    • Viard, Jean-Paul;
    • Gibowski, Severine;
    • Ollivier, Manon;
    • Costagliola, Dominique;
    • Molina, Jean-Michel
    Publication type:
    Article
    2

    ANRS 174 DOXYVAC: AN OPEN-LABEL RANDOMIZED TRIAL TO PREVENT STIs IN MSM ON PrEP.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 49
    By:
    • Molina, Jean-Michel;
    • Bercot, Beatrice;
    • Assoumou, Lambert;
    • Michele, Algarte-Genin;
    • Rubenstein, Emma;
    • Pialoux, Gilles;
    • Katlama, Christine;
    • Surgers, Laure;
    • Bebear, Cecile;
    • Dupin, Nicolas;
    • Viard, Jean-Paul;
    • Pavie, Juliette;
    • Duvivier, Claudine;
    • Ghosn, Jade;
    • Costagliola, Dominique
    Publication type:
    Article
    3

    Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 2, p. 546, doi. 10.3390/v15020546
    By:
    • Fofana, Djeneba B.;
    • Diarra, Houdou;
    • Guindo, Ibrahima;
    • Savadogo, Mahamadou K.;
    • d'Almeida, Marceline;
    • Diallo, Fatoumata I.;
    • Baldé, Aliou;
    • Soulié, Cathia;
    • Kone, Amadou;
    • Marcelin, Anne-Geneviève;
    • Maiga, Almoustapha I.;
    • Lambert-Niclot, Sidonie;
    • Maiga, Mamoudou;
    • McFall, Sally;
    • Hawkins, Claudia A.;
    • Murphy, Robert L.;
    • Sylla, Mariam;
    • Katlama, Christine;
    • Holl, Jane L.;
    • Calvez, Vincent
    Publication type:
    Article
    4
    5
    6

    Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials.

    Published in:
    Clinical Infectious Diseases, 2010, v. 50, n. 4, p. 605, doi. 10.1086/650002
    By:
    • Steigbigel, Roy T.;
    • Cooper, David A.;
    • Teppler, Hedy;
    • Eron, Joseph J.;
    • Gatell, Jose M.;
    • Kumar, Princy N.;
    • Rockstroh, Jurgen K.;
    • Schechter, Mauro;
    • Katlama, Christine;
    • Markowitz, Martin;
    • Yeni, Patrick;
    • Loutfy, Mona R.;
    • Lazzarin, Adriano;
    • Lennox, Jeffrey L.;
    • Clotet, Bonaventura;
    • Jing Zhao;
    • Hong Wan;
    • Rhodes, Rand R.;
    • Strohmaier, Kim M.;
    • Barnard, Richard J.
    Publication type:
    Article
    7

    Switch from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial.

    Published in:
    Clinical Infectious Diseases, 2009, v. 49, n. 8, p. 1259, doi. 10.1086/605674
    By:
    • de Castro, Nathalie;
    • Braun, Joséphine;
    • Charreau, Isabelle;
    • Pialoux, Gilles;
    • Cotte, Laurent;
    • Katlama, Christine;
    • Raffi, François;
    • Weiss, Laurence;
    • Meynard, Jean-Luc;
    • Yazdanpanah, Yazdan;
    • Delaugerre, Constance;
    • Madelaine-Chambrin, Isabelle;
    • Aboulker, Jean-Pierre;
    • Molina, Jean-Michel
    Publication type:
    Article
    8

    Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial.

    Published in:
    Clinical Infectious Diseases, 2006, v. 43, n. 10, p. 1347, doi. 10.1086/508352
    By:
    • Cahn, Pedro;
    • Villacian, Jorge;
    • Lazzarin, Adriano;
    • Katlama, Christine;
    • Grinsztejn, Beatriz;
    • Arasteh, Keikawus;
    • López, Paulo;
    • Clumeck, Nathan;
    • Gerstoft, Jan;
    • Stavrianeas, Nikolas;
    • Moreno, Santiago;
    • Antunes, Francisco;
    • Neubacher, Dietmar;
    • Mayers, Douglas
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.

    Published in:
    Cells (2073-4409), 2022, v. 11, n. 6, p. 1015, doi. 10.3390/cells11061015
    By:
    • Baron, Marine;
    • Soulié, Cathia;
    • Lavolé, Armelle;
    • Assoumou, Lambert;
    • Abbar, Baptiste;
    • Fouquet, Baptiste;
    • Rousseau, Alice;
    • Veyri, Marianne;
    • Samri, Assia;
    • Makinson, Alain;
    • Choquet, Sylvain;
    • Mazières, Julien;
    • Brosseau, Solenn;
    • Autran, Brigitte;
    • Costagliola, Dominique;
    • Katlama, Christine;
    • Cadranel, Jacques;
    • Marcelin, Anne-Geneviève;
    • Lambotte, Olivier;
    • Spano, Jean-Philippe
    Publication type:
    Article
    16

    Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 991, doi. 10.1093/cid/ciad297
    By:
    • Sempere, Abiu;
    • Assoumou, Lambert;
    • González-Cordón, Ana;
    • Waters, Laura;
    • Rusconi, Stefano;
    • Domingo, Pere;
    • Gompels, Mark;
    • Wit, Stephane de;
    • Raffi, François;
    • Stephan, Christoph;
    • Masiá, Mar;
    • Rockstroh, Jürgen;
    • Katlama, Christine;
    • Behrens, Georg M N;
    • Moyle, Graeme;
    • Johnson, Margaret;
    • Fox, Julie;
    • Stellbrink, Hans-Jürgen;
    • Guaraldi, Giovanni;
    • Florence, Eric
    Publication type:
    Article
    17

    Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.

    Published in:
    Clinical Infectious Diseases, 2023, v. 76, n. 5, p. 861, doi. 10.1093/cid/ciac827
    By:
    • Waters, Laura;
    • Assoumou, Lambert;
    • González-Cordón, Ana;
    • Rusconi, Stefano;
    • Domingo, Pere;
    • Gompels, Mark;
    • Wit, Stephane de;
    • Raffi, François;
    • Stephan, Christoph;
    • Masiá, Mar;
    • Rockstroh, Jürgen;
    • Katlama, Christine;
    • Behrens, Georg M N;
    • Moyle, Graeme;
    • Johnson, Margaret;
    • Fox, Julie;
    • Stellbrink, Hans-Jürgen;
    • Guaraldi, Giovanni;
    • Florence, Eric;
    • Esser, Stefan
    Publication type:
    Article
    18

    Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.

    Published in:
    Clinical Infectious Diseases, 2021, v. 72, n. 9, p. e215, doi. 10.1093/cid/ciaa1014
    By:
    • Tan, Boun Kim;
    • Chalouni, Mathieu;
    • Ceron, Dominique Salmon;
    • Cinaud, Alexandre;
    • Esterle, Laure;
    • Loko, Marc Arthur;
    • Katlama, Christine;
    • Poizot-Martin, Isabelle;
    • Neau, Didier;
    • Chas, Julie;
    • Morlat, Philippe;
    • Rosenthal, Eric;
    • Lacombe, Karine;
    • Naqvi, Alissa;
    • Barange, Karl;
    • Bouchaud, Olivier;
    • Gervais, Anne;
    • Lascoux-Combe, Caroline;
    • Garipuy, Daniel;
    • Alric, Laurent
    Publication type:
    Article
    19

    The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 10, p. e549, doi. 10.1093/cid/ciaa259
    By:
    • Gorwood, Jennifer;
    • Bourgeois, Christine;
    • Pourcher, Valérie;
    • Pourcher, Guillaume;
    • Charlotte, Frédéric;
    • Mantecon, Matthieu;
    • Rose, Cindy;
    • Morichon, Romain;
    • Atlan, Michael;
    • Grand, Roger Le;
    • Desjardins, Delphine;
    • Katlama, Christine;
    • Fève, Bruno;
    • Lambotte, Olivier;
    • Capeau, Jacqueline;
    • Béréziat, Véronique;
    • Lagathu, Claire
    Publication type:
    Article
    20

    Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 293, doi. 10.1093/cid/ciz800
    By:
    • Guillou, Adrien Le;
    • Pugliese, Pascal;
    • Raffi, François;
    • Cabie, André;
    • Cuzin, Lise;
    • Katlama, Christine;
    • Allavena, Clotilde;
    • Drame, Moustapha;
    • Cotte, Laurent;
    • Bani-Sadr, Firouzé;
    • Group, Dat'AIDS Study
    Publication type:
    Article
    21

    Recurrence and Occurrence of Kaposi's Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia.

    Published in:
    Clinical Infectious Diseases, 2020, v. 70, n. 11, p. 2435, doi. 10.1093/cid/ciz762
    By:
    • Palich, Romain;
    • Veyri, Marianne;
    • Valantin, Marc-Antoine;
    • Marcelin, Anne-Geneviève;
    • Guihot, Amélie;
    • Pourcher, Valérie;
    • Jary, Aude;
    • Solas, Caroline;
    • Makinson, Alain;
    • Poizot-Martin, Isabelle;
    • Costagliola, Dominique;
    • Spano, Jean-Philippe;
    • Katlama, Christine;
    • Group, for the CancerVIH Study
    Publication type:
    Article
    22

    Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial.

    Published in:
    AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00428-5
    By:
    • Hall, Nolwenn;
    • Allavena, Clotilde;
    • Katlama, Christine;
    • Jobert, Alexandra;
    • Molina, Jean-Michel;
    • Cua, Eric;
    • Bani-Sadr, Firouzé;
    • Hocqueloux, Laurent;
    • Duvivier, Claudine;
    • Merrien, Dominique;
    • Hikombo, Hitoto;
    • André-Garnier, Elisabeth;
    • Gaultier, Aurélie;
    • Raffi, François;
    • the QDISS Study Group;
    • Bollengier, Olivier;
    • Guimard, Thomas;
    • Leautez, Sophie;
    • Blanchi, Sophie;
    • Becker, Agathe
    Publication type:
    Article
    23

    Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 4, p. 749, doi. 10.1093/jac/dkq029
    By:
    • Soulié, Cathia;
    • Fourati, Slim;
    • Lambert-Niclot, Sidonie;
    • Malet, Isabelle;
    • Wirden, Marc;
    • Tubiana, Roland;
    • Valantin, Marc-Antoine;
    • Katlama, Christine;
    • Calvez, Vincent;
    • Marcelin, Anne-Geneviève
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 797
    By:
    • Claudine Duvivier;
    • Jade Ghosn;
    • Lambert Assoumou;
    • Cathia Soulié;
    • Gilles Peytavin;
    • Vincent Calvez;
    • Michèle Algarté Génin;
    • Jean-Michel Molina;
    • Olivier Bouchaud;
    • Christine Katlama;
    • Dominique Costagliola;
    • on behalf of the ANRS 121 study group
    Publication type:
    Article
    30

    Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 3, p. 456, doi. 10.1093/jac/dkn234
    By:
    • Anne Derache;
    • Almoustapha-Issiaka Maiga;
    • Ousmane Traore;
    • Alain Akonde;
    • Mamadou Cisse;
    • Bernard Jarrousse;
    • Victoria Koita;
    • Bah Diarra;
    • Guislaine Carcelain;
    • Francis Barin;
    • Cecilia Pizzocolo;
    • Louis Pizarro;
    • Christine Katlama;
    • Vincent Calvez;
    • Anne-Geneviève Marcelin
    Publication type:
    Article
    31

    Towards an HIV cure: a global scientific strategy.

    Published in:
    Nature Reviews Immunology, 2012, v. 12, n. 8, p. 607, doi. 10.1038/nri3262
    By:
    • Deeks, Steven G.;
    • Autran, Brigitte;
    • Berkhout, Ben;
    • Benkirane, Monsef;
    • Cairns, Scott;
    • Chomont, Nicolas;
    • Chun, Tae-Wook;
    • Churchill, Melissa;
    • Mascio, Michele Di;
    • Katlama, Christine;
    • Lafeuillade, Alain;
    • Landay, Alan;
    • Lederman, Michael;
    • Lewin, Sharon R.;
    • Maldarelli, Frank;
    • Margolis, David;
    • Markowitz, Martin;
    • Martinez-Picado, Javier;
    • Mullins, James I.;
    • Mellors, John
    Publication type:
    Article
    32

    Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.

    Published in:
    Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 583, doi. 10.3390/jpm13040583
    By:
    • Sellem, Baptiste;
    • Abdi, Basma;
    • Lê, Minh;
    • Tubiana, Roland;
    • Valantin, Marc-Antoine;
    • Seang, Sophie;
    • Schneider, Luminita;
    • Fayçal, Antoine;
    • Peytavin, Gilles;
    • Soulié, Cathia;
    • Marcelin, Anne-Geneviève;
    • Katlama, Christine;
    • Pourcher, Valérie;
    • Palich, Romain
    Publication type:
    Article
    33

    HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.

    Published in:
    PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0160341
    By:
    • Gach, Johannes S.;
    • Gorlani, Andrea;
    • Dotsey, Emmanuel Y.;
    • Becerra, Juan C.;
    • Anderson, Chase T. M.;
    • Berzins, Baiba;
    • Felgner, Philip L.;
    • Forthal, Donald N.;
    • Deeks, Steven G.;
    • Wilkin, Timothy J.;
    • Casazza, Joseph P.;
    • Koup, Richard A.;
    • Katlama, Christine;
    • Autran, Brigitte;
    • Murphy, Robert L.;
    • Achenbach, Chad J.
    Publication type:
    Article
    34
    35

    Relationship between mutations in HIV‐1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre‐treated HIV infected patientsThis work was presented in part during the XIV International HIV Drug Resistance Workshop, 7–11 June 2005, Quebec, Canada (Abstract 88).

    Published in:
    Journal of Medical Virology, 2007, v. 79, n. 3, p. 207, doi. 10.1002/jmv.20788
    By:
    • Bénédicte Roquebert;
    • Marc Wirden;
    • Anne Simon;
    • Jérome Deval;
    • Christine Katlama;
    • Vincent Calvez;
    • Anne‐Geneviève Marcelin
    Publication type:
    Article
    36
    37

    Virological and pharmacological factors associated with virological response to salvage therapy after an 8‐week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

    Published in:
    Journal of Medical Virology, 2005, v. 77, n. 3, p. 345
    By:
    • Constance Delaugerre;
    • Gilles Peytavin;
    • Stephanie Dominguez;
    • Anne‐Genevieve Marcelin;
    • Claudine Duvivier;
    • Karine Gourlain;
    • Bahia Amellal;
    • Mayeule Legrand;
    • François Raffi;
    • Dominique Costagliola;
    • Christine Katlama;
    • Vincent Calvez
    Publication type:
    Article
    38
    39

    Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patientsThis work was presented during the 2nd IAS Conference on HIV Pathogenesis and Treatment. 13–16 July 2003, Paris, France (abstract 165).

    Published in:
    Journal of Medical Virology, 2004, v. 74, n. 1, p. 16
    By:
    • Anne‐Geneviève Marcelin;
    • Dissou Affolabi;
    • Claire Lamotte;
    • Hocine Ait Mohand;
    • Constance Delaugerre;
    • Marc Wirden;
    • Delphine Voujon;
    • Philippe Bossi;
    • Nadine Ktorza;
    • François Bricaire;
    • Dominique Costagliola;
    • Christine Katlama;
    • Gilles Peytavin;
    • Vincent Calvez
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50